» Articles » PMID: 30412108

Oriental Herbal Medicine and Moxibustion for Polycystic Ovary Syndrome: A Meta-analysis

Overview
Specialty General Medicine
Date 2018 Nov 10
PMID 30412108
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Polycystic ovary syndrome (PCOS) is one of the most common disorders of reproductive endocrinology in women of reproductive age. Lifestyle intervention and oral contraceptives are the first-line treatments for PCOS. Recent studies have suggested that complementary and alternative medicine (CAM) therapies including acupuncture, herbal medicine, and mind-body therapy have the potential to alleviate the symptoms and/or pathology of PCOS and to improve the quality of life of women with PCOS. This meta-analysis aimed to quantitatively summarize the efficacy and safety of moxibustion combined with oriental herbal medicine (OHM), common CAM therapies, for treating PCOS.

Methods: Four databases were searched from their inception to June 22, 2018. Randomized controlled trials (RCTs) and quasi-RCTs using both OHM and moxibustion as experimental intervention, and western medication (WM) as control intervention were included. Studies involving OHM plus moxibustion combined with WM as the experimental intervention were also included. The quality of included studies was assessed using risk of bias tool.

Results: Owing to the heterogeneity of reporting, meta-analysis was only performed for pregnancy rate, rate of normal biphasic basal body temperature (BBT), and total effective rate (TER). The results showed that compared to the WM group, the OHM combined with moxibustion group was associated with significantly higher pregnancy rate (risk ratio [RR] 1.95, 95% confidence interval [CI] 1.55-2.47; I = 0%), normal biphasic BBT rate (RR 1.66, 95% CI 1.34-2.05; I = 0%), and TER (RR 1.19, 95% CI 1.08-1.31; I = 0%). When OHM combined with moxibustion was used as an adjunctive therapy to WM, pregnancy rate (RR 1.65, 95% CI 1.29-2.11; I = 0%), and TER (RR 1.35, 95% CI 1.13-1.61; I = 43%) were significantly higher than those of the WM group.

Conclusion: According to current evidence, OHM combined with moxibustion might be beneficial for treating PCOS. Moreover, the treatment might improve the therapeutic effects of conventional WMs including clomiphene citrate, oral contraceptives, and/or metformin. However, the findings should be interpreted with caution, owing to poor methodological quality of the included studies. Further larger, high-quality, rigorous RCTs should be conducted in this regard.

Citing Articles

"Ferula assa-foetida L" or "Foeniculum vulgare"? Which one is more effective in the management of polycystic ovarian syndrome? A randomized, placebo controlled, triple-blinded.

Ghavi F, Shakeri F, Abdolahian S Avicenna J Phytomed. 2023; 13(3):280-289.

PMID: 37655000 PMC: 10465881. DOI: 10.22038/AJP.2022.21389.


Herbs as a Source for the Treatment of Polycystic Ovarian Syndrome: A Systematic Review.

Lakshmi J, Babu A, Kiran S, Nori L, Hassan N, Ashames A BioTech (Basel). 2023; 12(1).

PMID: 36648830 PMC: 9844343. DOI: 10.3390/biotech12010004.


Treatment of Cesarean Scar Pregnancy with Traditional Chinese Medicine and Warming Moxibustion.

Cai X, Shi H, Dai S, Wang J, Lu B, Zhang Q Evid Based Complement Alternat Med. 2022; 2022:5835569.

PMID: 35620401 PMC: 9129969. DOI: 10.1155/2022/5835569.


Effects of Acupuncture Combined with Moxibustion on Reproductive and Metabolic Outcomes in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Li P, Peng J, Ding Z, Zhou X, Liang R Evid Based Complement Alternat Med. 2022; 2022:3616036.

PMID: 35399633 PMC: 8991411. DOI: 10.1155/2022/3616036.


Evidence for the Use of Complementary and Alternative Medicine for Pelvic Inflammatory Disease: A Literature Review.

Wang D, Jiang Y, Feng J, Gao J, Yu J, Zhao J Evid Based Complement Alternat Med. 2022; 2022:1364297.

PMID: 35096102 PMC: 8791705. DOI: 10.1155/2022/1364297.


References
1.
Nasri H, Rafieian-Kopaei M . Metformin: Current knowledge. J Res Med Sci. 2014; 19(7):658-64. PMC: 4214027. View

2.
Borenstein M, Hedges L, Higgins J, Rothstein H . A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2015; 1(2):97-111. DOI: 10.1002/jrsm.12. View

3.
Zhao H, Zhou D, Chen Y, Liu D, Chu S, Zhang S . Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway. Daru. 2017; 25(1):21. PMC: 5637260. DOI: 10.1186/s40199-017-0188-7. View

4.
Legro R, Zaino R, Demers L, Kunselman A, Gnatuk C, Williams N . The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome. Am J Obstet Gynecol. 2007; 196(4):402.e1-10. DOI: 10.1016/j.ajog.2006.12.025. View

5.
Lu D, Lu G . Clinical management of needle-phobia patients requiring acupuncture therapy. Acupunct Electrother Res. 2000; 24(3-4):189-201. DOI: 10.3727/036012999816356282. View